PARIS--(BUSINESS WIRE)--France Biotech (www.france-biotech.org), an association of Entrepreneurs in Life Sciences announces the first edition of "French Life Sciences Days", a major event that brings together the Life Sciences French companies listed on stock market with North American and French financial communities. During this event, the French companies Biotech and Medtech, both listed on stock market will introduce themselves to North American specialized investments funds on June 25 and 26 in New York.
The main players in Paris (banks, brokers, analysts, auditors, lawyers, communication agencies) gathered in one sponsorship committee will accompany the entrepreneurs.
On this occasion, the French Life Sciences companies listed on NYSE Euronext will introduces themselves before international investors. This new initiative of France Biotech aims to strengthen the links between French listed companies and North American investors and thus promote transatlantic trade while demonstrating the strength of our financial market.
"The U.S. specialized investment funds are interested in our business, which demonstrates the completeness of our innovations. Presenting ourselves as a group and as an ecosystem will strengthen their will to sustainably invest in our companies. The momentum is highly favorable, it is an opportunity not to be missed", said Pierre-Olivier GOINEAU, President of France Biotech.
About France Biotech
France Biotech brings together French life science companies and their expert partners. Its mission is to support the development of the French life sciences by working for a favorable legislative and fiscal environment. France Biotech catalyzed the French government's creation of a special fiscal status for start-ups in 2004 and continues to act as an advocate for this innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder and CEO of ERYTECH Pharma. France Biotech has over 150 members and is governed by a Board of 20 life science entrepreneurs.